Devices to Detect Skin Cancer: FDA Advisers Offer Mixed Views
US regulators heard conflicting views from an expert panel about steps that might smooth the way for new tools to aid in diagnosing skin cancer.
New York United States Memorial Sloan Kettering Cancer Center United Kingdom Chevy Chase Karlav Ballman
Source: medscape.com